Joseph Monahan, Chief Scientific Officer at Aclaris Therapeutics, Inc. (ACRS), sold 5,000 shares at $15.88 ($79K) on 2022-12-15, disclosed to the SEC on 2022-12-16.
Open-market sale of $79k ACRS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ACRS | SELL | 2023-06-22 | $123K | — | Filing → |
| ACRS | SELL | 2023-03-03 | $588K | — | Filing → |
| ACRS | SELL | 2023-02-17 | $65K | — | Filing → |